AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Claglid-M 80mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Proqol Healthcare

Salt Composition

Gliclazide (80mg) + Metformin (500mg)

Overview Claglid-M 80mg/500mg Tablet

DiaBeta Duo 80mg/500mg tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Administer DiaBeta Duo with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is vital; discontinuation without medical supervision can lead to elevated blood sugar, potentially resulting in kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Common side effects of DiaBeta Duo include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. Always carry a rapid-acting glucose source, such as fruit juice or sweets, and know how to manage hypoglycemic episodes. Regular meals are crucial for prevention. Alcohol consumption elevates hypoglycemia risk and should be limited. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain is also possible. DiaBeta Duo is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Its suitability for pregnant or breastfeeding women requires medical consultation. Regular blood glucose monitoring is essential, and your doctor may order blood tests to track blood cell counts and liver function.

Uses of Claglid-M 80mg/500mg Tablet

Adult-onset diabetes

Major Benefits of Claglid-M 80mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Claglid-M 80mg/500mg tablets with food.

Common Side effects of Claglid-M 80mg/500mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Claglid-M 80mg/500mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Claglid-M 80mg/500mg tablets should be administered with a meal.

How Claglid-M 80mg/500mg Tablet works:

Each Claglid-M 80mg/500mg tablet contains gliclazide and metformin, two medications used to manage blood sugar levels in diabetes.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol consumption with Claglid-M 80mg/500mg tablets is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Claglid-M 80mg/500mg tablets is contraindicated during pregnancy due to established fetal risks. Nevertheless, a physician might exceptionally prescribe it in critical circumstances where potential benefits outweigh the hazards. Physician consultation is essential.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Claglid-M 80mg/500mg tablets while breastfeeding is likely inadvisable. Available evidence from human studies indicates potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Claglid-M 80mg/500mg tablets, potentially requiring dosage modification. Consult your physician for guidance. Claglid-M 80mg/500mg tablets are contraindicated in individuals with severe kidney disease. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Claglid-M 80mg/500mg tablets cautiously, potentially requiring dosage modification. Individuals with mild to moderate liver disease should begin with a low dose; the medication is contraindicated in those with severe liver disease. Physician consultation is advised.

What if you forget to take Claglid-M 80mg/500mg Tablet :

Should you forget to take a Claglid-M 80mg/500mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed tablet and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Claglid-M 80mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Claglid-M 80mg/500mg Tablet

Claglid-M 80mg/500mg tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with a healthy diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It is not suitable for type 1 diabetes.
Claglid-M 80mg/500mg tablets may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Claglid-M 80mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Claglid-M 80mg/500mg Tablets can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency involving high blood lactic acid levels. This rare side effect is preventable by avoiding use in patients with kidney disease, the elderly, or heavy alcohol users. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Claglid-M 80mg/500mg Tablets and seek immediate medical attention.
Prolonged use of Claglid-M 80mg/500mg tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Claglid-M 80mg/500mg Tablets are contraindicated in patients with known allergies to any ingredient or excipient. Use is also contraindicated in those with moderate to severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Combining Claglid-M 80mg/500mg tablets with alcohol is unsafe. This combination can worsen low blood sugar and raise the risk of lactic acidosis.
Claglid-M 80mg/500mg tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Claglid-M 80mg/500mg tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Claglid-M 80mg/500mg Tablets can cause low blood sugar (hypoglycemia), characterized by nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Claglid-M 80mg/500mg Tablets can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect is preventable by avoiding use in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Claglid-M 80mg/500mg Tablets and seek immediate medical attention.
Prolonged use of Claglid-M 80mg/500mg tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 intake is recommended by some researchers.
Claglid-M 80mg/500mg Tablets are contraindicated in patients with allergies to any ingredient or excipient, and in those with moderate to severe kidney disease or metabolic acidosis (including diabetic ketoacidosis).
Combining Claglid-M 80mg/500mg tablets with alcohol is unsafe. Alcohol can worsen low blood sugar and raise the risk of lactic acidosis.
Claglid-M 80mg/500mg Tabl...
48
MRP 59
18% off